What the business is, and whether it's a good one at a fair price.
A Healthcare Services company listed on BSE, reporting revenue of ₹23 Cr over the trailing twelve months.
Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY25 — not investment advice
How has the market priced it — with filings on the timeline?
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
How does it stack up on valuation, returns and growth?
Loading peers…
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Answered from Aspira Pathlab & Diagnostics L's filed financials and exchange disclosures
Aspira Pathlab & Diagnostics L is a Healthcare Services company listed on BSE.
Yes. Over the trailing twelve months Aspira Pathlab & Diagnostics L reported a net profit of ₹2 Cr on revenue of ₹23 Cr.
Not in the latest reported year — Aspira Pathlab & Diagnostics L's dividend payout for FY25 was nil.
Effectively yes. It holds ₹1 Cr more cash than debt. Debt stands at 0.10× equity.
On trailing P/E, Aspira Pathlab & Diagnostics L ranks 19 of 29 in Healthcare Service Provider — cheaper than 36% of them, against an industry median of 23.2×. This is a position, not a valuation judgement.
On a typical session Aspira Pathlab & Diagnostics L moves 1.99% — that is the median absolute close-to-close move across its last 268 trading days. Announcement days are routinely larger.
Every NSE and BSE filing by Aspira Pathlab & Diagnostics L appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.
